CL King and Associates Revenue and Competitors

Albany, NY USA

Location

N/A

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • CL King and Associates's estimated annual revenue is currently $55.4M per year.(i)
  • CL King and Associates's estimated revenue per employee is $231,000

Employee Data

  • CL King and Associates has 240 Employees.(i)

CL King and Associates's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
SVPReveal Email/Phone
3
Senior Managing Director, Head Fixed IncomeReveal Email/Phone
4
President Reveal Email/Phone
5
N/AReveal Email/Phone
6
Investment Banking AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$55.4M240N/AN/AN/A
Add Company

What Is CL King and Associates?

CL King & Associates is a client-driven institutional research boutique that provides value-added research to institutional equity investors whose priority is to make superior absolute returns while minimizing downside risk. CL King analysts seek out misperceived stocks in many sectors while maintaining continuity in certain broad areas of expertise.

keywords:N/A

N/A

Total Funding

240

Number of Employees

$55.4M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

CL King and Associates News

2022-04-20 - Q3 2022 EPS Estimates for The Chefs' Warehouse, Inc ...

CL King boosted their target price on shares of Chefs' Warehouse from $34.00 to $38.00 in a report on Thursday, April 14th.

2022-04-20 - Robert Half International (NYSE:RHI) Rating Increased to ...

CL King boosted their target price on Robert Half International from $128.00 to $132.00 in a research report on Wednesday.

2022-04-06 - CMC Materials (NASDAQ:CCMP) Downgraded by CL King to ...

CL King downgraded shares of CMC Materials (NASDAQ:CCMP – Get Rating) from a buy rating to a neutral rating in a report issued on Thursday,...

2011-01-17 - Invacare: How much will ‘burning beds’ warning letter hurt the company?

“This one struck me as more egregious than a typical warning letter,” said Robert Goldman, a long-time medical equities analyst with C.L. King & Associates in New York. “Most are resolved quietly without much attention, with no impact on the company or its stock. But every once in awhile you get ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$26.1M2438%$28.8M
#2
$34.3M2603%N/A
#3
$96.2M2657%N/A
#4
$52.7M266N/AN/A
#5
$35M2703%N/A